Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05775991 · ClinicalTrials.gov registry record
COACH-Cog Intervention Adaptation Focus Groups
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 18
- Enrollment target
NCT05775991: Completed study, sponsored by University of Rochester.
NCT05775991 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05775991 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
To gather key stakeholder input for feedback on the adaption of the COACH GA intervention (i.e., develop COACH-Cog) to enhance triadic communication among oncologists, care partners and patients with ADRD.
Primary Outcome
Qualitative data gathered from participants during focus group participation. Focus groups will be audio-recorded and transcribed. Transcribed audio-recordings will be qualitatively analyzed for positive regard for the intervention and opportunities and recommendations for further intervention adaptation. Open coding using content analysis framework will be utilized for qualitative analysis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2023-09-12 |
What the finished NCT05775991 record still lists
NCT05775991 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05775991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05775991 about?
NCT05775991 is a clinical study titled "COACH-Cog Intervention Adaptation Focus Groups". To gather key stakeholder input for feedback on the adaption of the COACH GA intervention (i.e., develop COACH-Cog) to enhance triadic communication among oncologists, care partners and patients with ADRD.
What is the current status of trial NCT05775991?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2023-03-15. Estimated completion is 2023-09-12.
Who is sponsoring clinical trial NCT05775991?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI